Restful Legs Pm Tablet
NDC Package 54973-3352-2
Package Information
Restful Legs Pm (anemone patens, matricaria chamomilla, sulfur, zinc, toxicodendron pubescens leaf, arsenic trioxide, arabica coffee bean, lycopodium clavatum spore) tablets is adults and Children 12 years and overDissolve 2-3 tablets under tongue before bed to fall asleep, stay asleep, and relieve agitation of legs. This formulation utilizes a tablet delivery system. Marketed by Hyland's Inc., this product is identified by NDC 54973-3352.
Identification & Billing
Clinical Specifications
- Allergens - [CS]
- Cell-mediated Immunity - [PE] (Physiologic Effect)
- Dietary Proteins - [CS]
- Increased Histamine Release - [PE] (Physiologic Effect)
- Non-Standardized Food Allergenic Extract - [EPC] (Established Pharmacologic Class)
- Non-Standardized Plant Allergenic Extract - [EPC] (Established Pharmacologic Class)
- Plant Proteins - [CS]
- Seed Storage Proteins - [CS]
Regulatory & Marketing
Hierarchy Structure
- 54973 - Hyland's Inc.
- 54973-3352 - Restful Legs Pm
- 54973-3352-2 - 4 TABLET in 1 PACKET
- 54973-3352 - Restful Legs Pm
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Other Available Packages
The following commercial packages are registered under the same Product NDC (54973-3352). Click a package code to view its specific billing and regulatory data.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 54973-3352-2 identifies a specific commercial package of 4 tablet in 1 packet of Restful Legs Pm, a human over the counter drug labeled by Hyland's Inc.. This tablet is formulated for oral use and contains arabica coffee bean; arsenic trioxide; lycopodium clavatum spore; matricaria chamomilla; pulsatilla patens whole; sulfur; toxicodendron pubescens leaf; zinc as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Hyland's Inc. on March 14, 2018. The current certification is valid through December 31, 2026.
How is this Hyland's Inc. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 54973335202. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Package segment to maintain the 5-4-2 structure.